The Syneos Health Dealmakers’ Intentions Study is a forward-looking measure of dealmaking activity in the pharmaceutical and biotech industries. While there are many quality sources of information that look historically at past deal trends, this survey offers a prospective view of the partnering and licensing landscape for the year ahead. This survey provides a unique perspective on these trends – by surveying business development professionals from pharmaceutical and biotechnology companies of all sizes, we are able to generate forward-looking insights based on dealmakers' general expectations for activity in the coming year.
Past Reports
